openPR Logo
Press release

Embolotherapy Market Size Expected to Hit $10.68 Billion by 2032

08-28-2024 12:05 PM CET | Health & Medicine

Press release from: Value Market Research

Embolotherapy Market Size Expected to Hit $10.68 Billion by 2032

According to Value Market Research, the global Embolotherapy Market size is anticipated to experience significant growth, with expectations to reach nearly USD 10.68 billion by 2032, up from USD 4.87 billion in 2023. This growth corresponds to a robust compound annual growth rate (CAGR) of 9.12% during the forecast period from 2024 to 2032. The expansion of the market is attributed to advancements in embolotherapy technologies, increasing prevalence of chronic diseases requiring embolization procedures, and a rising preference for minimally invasive treatments. Additionally, the growing adoption of embolotherapy for various applications, including oncology and vascular malformations, is driving the market's upward trajectory, highlighting its expanding role in modern medical treatments.

The major players in the Embolotherapy market include Merit Medical Systems, Boston Scientific Corporation, Medtronic Plc, Meril Life Sciences Pvt. Ltd.

Get more information on "Global Embolotherapy Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/embolotherapy-market/download-sample

The embolotherapy market is on a growth trajectory, fueled by innovations in technology, increasing disease prevalence, and rising demand for minimally invasive procedures. With continued advancements and expanding applications, the market is set to evolve significantly, offering new opportunities for stakeholders and improving patient outcomes worldwide.

The global embolotherapy market is poised for significant growth in the coming decade, driven by advancements in medical technology, increasing prevalence of chronic diseases, and rising awareness about minimally invasive procedures. This report provides a comprehensive analysis of the embolotherapy market segmented by product, disease indication, procedure, end-user, and region, offering insights into industry trends, size, share, growth, estimation, and forecasts from 2023 to 2032.

Market Segmentation:

By Product

Embolic Agents: These include agents used to obstruct blood flow within blood vessels. Commonly used agents include particles, beads, and foams.
Microspheres: These are tiny spheres used in embolization to block blood vessels. They can be made from various materials such as polymer, glass, or gelatin.
Embolic Coils: These come in two main types:
Detachable Coils: Allow for precise placement and control during embolization procedures.
Pushable Coils: Delivered through a catheter and pushed into the target vessel.
Liquid Embolic Agents: These agents are used to occlude blood vessels and include materials like N-butyl cyanoacrylate (NBCA) and ethylene vinyl alcohol copolymer (EVOH).
Embolic Plug Systems: These devices include plug-like structures that are deployed to occlude blood vessels.
Detachable Balloons: Used to block blood flow temporarily during procedures.
Support Devices: Include various accessories that aid in the embolization process, such as balloons and guidewires.
Microcatheters: Small, flexible catheters used to deliver embolic agents precisely to the target area.
Guidewires: Used to navigate catheters and other devices through the vascular system.

Browse Global Embolotherapy Market Research Report with detailed TOC at https://www.valuemarketresearch.com/report/embolotherapy-market

By Disease Indication:

Cancer: Includes various types of cancer where embolotherapy is used as a treatment or palliative measure.
Liver Cancer: Specific focus on hepatic embolization techniques.
Kidney Cancer: Treatment involving renal embolization.
Other Cancers: Includes tumors located in other organs.
Peripheral Vascular Diseases: Conditions affecting the blood vessels outside the heart and brain.
Neurological Diseases: Includes disorders affecting the brain and spinal cord.
Cerebral Aneurysm: Embolization used to treat aneurysms in the brain.
Cerebral Arteriovenous Malformations and Fistulas: Embolization techniques used to manage these conditions.
Gastrointestinal Disorders: Embolotherapy for gastrointestinal bleeding and other disorders.
Urological and Nephrological Disorders: Includes treatments for disorders affecting the urinary system and kidneys.

By Procedure Analysis:

Transcatheter Arterial Embolization (TAE): A procedure used to block blood flow to a specific area by injecting embolic agents through a catheter.
Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy (SIRT): Combines embolization with localized radiation therapy.
Transarterial Chemoembolization (TACE): Combines chemotherapy with embolization to treat cancerous tumors.

By End User Analysis:

Hospitals and Clinics: The primary settings for embolotherapy procedures due to advanced medical infrastructure.
Ambulatory Surgical Centers: Facilities that provide outpatient services and increasingly perform embolotherapy procedures.
Other End Users: Includes specialized centers and research institutions.

By Region:

North America: Dominated by advanced healthcare systems, high adoption of new technologies, and significant research and development activities.
Europe: Features a well-established healthcare infrastructure and increasing investment in minimally invasive procedures.
Asia-Pacific: Rapidly growing market due to improving healthcare infrastructure, increasing prevalence of chronic diseases, and rising awareness about advanced medical technologies.
Latin America: Emerging market with increasing healthcare expenditures and growing demand for innovative treatment options.
Middle East & Africa: Market expansion driven by improving healthcare facilities and increasing investment in healthcare infrastructure.

Purchase Complete Global Embolotherapy Market Research Report at https://www.valuemarketresearch.com/contact/embolotherapy-market/buy-now

Industry Trends:

Technological Advancements: Continuous innovation in embolic materials and devices, such as the development of next-generation embolic coils and liquid agents, is enhancing the efficacy and safety of embolotherapy procedures.

Minimally Invasive Procedures: There is a growing preference for minimally invasive techniques due to their advantages over traditional surgical methods, including reduced recovery time and fewer complications.

Increasing Incidence of Chronic Diseases: The rising prevalence of conditions such as cancer, vascular diseases, and neurological disorders is driving demand for embolotherapy.

Regional Growth: The Asia-Pacific region is expected to witness the highest growth rate, driven by expanding healthcare infrastructure and increasing awareness of advanced treatment options.

Market Size and Forecast:

The global embolotherapy market is projected to experience robust growth from 2023 to 2032. The market size is anticipated to expand significantly, with a substantial compound annual growth rate (CAGR) over the forecast period. Key factors contributing to this growth include technological advancements, increasing prevalence of chronic diseases, and expanding healthcare infrastructure in emerging markets.

Contact:

Value Market Research
UG-203, Gera Imperium Rise,
Wipro Circle Metro Station, Hinjawadi, Pune - 411057
Maharashtra, INDIA.
Tel: +1-888-294-1147
Email: sales@valuemarketresearch.com
Website: https://www.valuemarketresearch.com

About Us:
Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information.
We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Embolotherapy Market Size Expected to Hit $10.68 Billion by 2032 here

News-ID: 3637628 • Views:

More Releases from Value Market Research

Organic Baby Food Market Size Set to Reach $10.37 Billion by 2032
Organic Baby Food Market Size Set to Reach $10.37 Billion by 2032
The global demand for the organic baby food market size is projected to surge significantly, with expectations of reaching a market size of approximately USD 10.37 billion by 2032, up from USD 4.73 billion in 2023. This growth represents a robust compound annual growth rate (CAGR) of 9.12% during the study period from 2024 to 2032. Factors driving this demand include increasing health consciousness among parents, a rising preference for
Capsule Hotel Market Size Expected to Reach USD 5.38 Billion by 2032
Capsule Hotel Market Size Expected to Reach USD 5.38 Billion by 2032
The global Capsule Hotel Market Size is projected to experience significant growth, with an anticipated market size of approximately USD 5,384.51 million by 2032, up from USD 2,170.92 million in 2023. This growth represents a robust compound annual growth rate (CAGR) of 10.62% over the study period from 2024 to 2032. This surge in demand can be attributed to the increasing popularity of budget-friendly and space-efficient accommodation options among travelers,
Terpenes Market Size Hits USD 518.84 Million in 2023, Projected to Grow at 5.47% CAGR by 2032
Terpenes Market Size Hits USD 518.84 Million in 2023, Projected to Grow at 5.47% …
The global terpenes market size was valued at USD 518.84 million in 2023 and is poised for significant growth over the next decade. Driven by increasing demand across various industries such as pharmaceuticals, cosmetics, and food and beverages, the market is projected to expand at a compound annual growth rate (CAGR) of 5.47% between 2024 and 2032. In terms of volume, the global terpenes market accounted for 108,036.67 tons in
Optical Coating Market Size Hits USD 50.81 Billion by 2032, Driven by 10.2% CAGR
Optical Coating Market Size Hits USD 50.81 Billion by 2032, Driven by 10.2% CAGR
The global demand for the optical coating market size is projected to experience significant growth, with the market size expected to reach nearly USD 50.81 billion by 2032, up from USD 21.2 billion in 2023. This represents a compound annual growth rate (CAGR) of 10.2% over the forecast period from 2024 to 2032. Optical coatings, which enhance the transmission, reflection, and absorption properties of optical components, are becoming increasingly important

All 5 Releases


More Releases for Embolotherapy

Embolotherapy Market Future Prediction Report By 2031
Embolotherapy Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics. Request Sample
Embolotherapy Market Revenue to Reach US$ 5,758.28 Million by 2028
The embolotherapy market is expected to grow from US$ 3,341.49 million in 2021 to US$ 5,758.28 million by 2028; it is estimated to grow at a CAGR of 8.1% from 2022 to 2028. According to our new research study on "Embolotherapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product, Disease Indication, Procedure, and End User," the market is expected to grow from US$ 3,341.49 million in
Embolotherapy Market 2023 Size, Share, Growth Report 2030
Latest Updated Report 2023, The Global Embolotherapy Market to Growing A CAGR of % during forecast period of 2023-2030. The Market is segmented by Global Embolotherapy Market Breakdown by Application (Hospitals and Clinics, Ambulatory Surgical Centers, Other End Users) by Type (Embolic Agents, Microspheres, Embolic Coils, Liquid Embolic Agents, Embolic Plug Systems, Detachable Balloons, Support Devices, Microcatheters, Guidewires) and by Geography (North America, South America, Europe, Asia Pacific, MEA). The Embolotherapy
Embolotherapy Market Growth, Development and Demand Forecast Report, 2030
The National Cancer Institute, under the U.S. Department of Health and Human Services, states that 76,080 new cases of kidney and renal pelvic cancer were diagnosed in the U.S. in 2021. Further, the Brain Aneurysm Foundation estimates that over 30,000 people suffer a brain aneurysm rupture every year in the U.S. Likewise, Brain Foundation of Migraine and Headache Australia states that approximately more than 2% of adults suffer from aneurysms
Embolotherapy Market 2022 - 2028 Worldwide Major Industry Players' Review
The "Global Embolotherapy Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Embolotherapy Market with detailed market segmentation by type, application, end user and geography. The global Embolotherapy Market is expected to witness high growth during the forecast period. The report provides key statistics on the
Embolotherapy Market To Generate $6,447.1 Million Revenue by 2030
A number of factors, such as the rising incidence of lifestyle-associated and chronic illnesses, growing aging population, surging patient pool, increasing healthcare spending, growing medical tourism industry, and enhancing healthcare infrastructure, are projected to propel the growth of the embolotherapy market at CAGR of 7.7% during the forecast period (2020–2030). According to P&S Intelligence, the market size is expected to reach $6,447.1 million by 2030 from $3,082.9 million in 2020.